| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 25 | 2025 | 623 | 6.020 |
Why?
|
| Regeneration | 13 | 2021 | 203 | 4.900 |
Why?
|
| Heart | 12 | 2023 | 724 | 4.240 |
Why?
|
| Organogenesis | 7 | 2025 | 79 | 2.410 |
Why?
|
| Myocardial Infarction | 10 | 2023 | 1022 | 2.390 |
Why?
|
| Phosphoproteins | 7 | 2019 | 404 | 1.970 |
Why?
|
| Signal Transduction | 18 | 2023 | 4542 | 1.970 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2019 | 537 | 1.960 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2022 | 467 | 1.780 |
Why?
|
| Cell Cycle Proteins | 10 | 2022 | 647 | 1.750 |
Why?
|
| Cell Proliferation | 17 | 2023 | 2305 | 1.520 |
Why?
|
| Eclampsia | 5 | 2017 | 29 | 1.460 |
Why?
|
| MicroRNAs | 10 | 2018 | 842 | 1.440 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 546 | 1.420 |
Why?
|
| Fibroblasts | 6 | 2022 | 891 | 1.370 |
Why?
|
| Heart Diseases | 5 | 2018 | 494 | 1.360 |
Why?
|
| Animals | 67 | 2025 | 34186 | 1.310 |
Why?
|
| Transcription Factors | 10 | 2021 | 2610 | 1.270 |
Why?
|
| Myocardium | 9 | 2021 | 1008 | 1.190 |
Why?
|
| Mitochondria | 3 | 2024 | 692 | 1.160 |
Why?
|
| Cell Nucleus | 2 | 2021 | 677 | 1.100 |
Why?
|
| Pre-Eclampsia | 5 | 2018 | 221 | 1.030 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2025 | 1001 | 0.990 |
Why?
|
| Skull | 3 | 2022 | 142 | 0.990 |
Why?
|
| Cell Differentiation | 16 | 2025 | 1929 | 0.900 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 47 | 0.890 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2017 | 74 | 0.890 |
Why?
|
| Mice | 37 | 2025 | 17748 | 0.880 |
Why?
|
| Neural Crest | 2 | 2015 | 51 | 0.870 |
Why?
|
| Ependymoglial Cells | 2 | 2019 | 5 | 0.830 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2013 | 37 | 0.820 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2019 | 35 | 0.790 |
Why?
|
| Actins | 1 | 2024 | 342 | 0.780 |
Why?
|
| Fibrosis | 3 | 2022 | 437 | 0.780 |
Why?
|
| Diabetes, Gestational | 1 | 2023 | 112 | 0.770 |
Why?
|
| Purkinje Fibers | 1 | 2021 | 6 | 0.750 |
Why?
|
| Cellular Reprogramming | 2 | 2019 | 116 | 0.740 |
Why?
|
| Cell Fractionation | 1 | 2021 | 36 | 0.730 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 24 | 0.710 |
Why?
|
| Congenital Abnormalities | 1 | 2023 | 254 | 0.710 |
Why?
|
| Cytokinesis | 1 | 2020 | 27 | 0.700 |
Why?
|
| Heart Conduction System | 1 | 2021 | 147 | 0.690 |
Why?
|
| Zebrafish | 1 | 2023 | 388 | 0.690 |
Why?
|
| Integrases | 1 | 2021 | 161 | 0.690 |
Why?
|
| Chromatin | 3 | 2025 | 556 | 0.680 |
Why?
|
| Epigenomics | 1 | 2021 | 164 | 0.670 |
Why?
|
| Pregnancy Outcome | 3 | 2016 | 589 | 0.660 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2019 | 22 | 0.660 |
Why?
|
| Heart Valves | 1 | 2019 | 52 | 0.630 |
Why?
|
| Transcriptome | 6 | 2025 | 938 | 0.630 |
Why?
|
| Postpartum Period | 3 | 2017 | 216 | 0.630 |
Why?
|
| Single-Cell Analysis | 5 | 2025 | 275 | 0.620 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 176 | 0.600 |
Why?
|
| Adipogenesis | 1 | 2018 | 77 | 0.580 |
Why?
|
| Obstetrics | 2 | 2017 | 237 | 0.580 |
Why?
|
| Pericardium | 1 | 2018 | 82 | 0.570 |
Why?
|
| Tocolysis | 1 | 2017 | 5 | 0.560 |
Why?
|
| Heart Failure, Systolic | 1 | 2017 | 32 | 0.560 |
Why?
|
| Wound Healing | 2 | 2023 | 458 | 0.560 |
Why?
|
| Pregnancy | 19 | 2023 | 7172 | 0.540 |
Why?
|
| Mice, Knockout | 13 | 2022 | 3753 | 0.540 |
Why?
|
| HELLP Syndrome | 3 | 2012 | 18 | 0.540 |
Why?
|
| Obstetric Labor, Premature | 1 | 2017 | 85 | 0.530 |
Why?
|
| Pulmonary Edema | 1 | 2016 | 48 | 0.530 |
Why?
|
| Sarcomeres | 2 | 2013 | 30 | 0.520 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 96 | 0.520 |
Why?
|
| Heart Injuries | 1 | 2016 | 46 | 0.510 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 233 | 0.510 |
Why?
|
| Humans | 44 | 2025 | 124797 | 0.500 |
Why?
|
| Mandible | 2 | 2015 | 79 | 0.490 |
Why?
|
| Aging | 2 | 2019 | 1189 | 0.480 |
Why?
|
| Antioxidants | 3 | 2016 | 336 | 0.480 |
Why?
|
| Phenotype | 2 | 2022 | 4261 | 0.470 |
Why?
|
| Infant Welfare | 1 | 2014 | 28 | 0.460 |
Why?
|
| Heart Failure | 3 | 2023 | 2302 | 0.460 |
Why?
|
| Maternal Welfare | 1 | 2014 | 14 | 0.460 |
Why?
|
| Face | 1 | 2015 | 180 | 0.460 |
Why?
|
| Embryo, Mammalian | 7 | 2022 | 456 | 0.460 |
Why?
|
| Cardiography, Impedance | 1 | 2014 | 10 | 0.450 |
Why?
|
| Mice, Transgenic | 7 | 2021 | 2410 | 0.450 |
Why?
|
| Transcription Factor AP-2 | 1 | 2013 | 22 | 0.440 |
Why?
|
| Transcription, Genetic | 6 | 2020 | 1704 | 0.430 |
Why?
|
| Heart Defects, Congenital | 3 | 2022 | 1813 | 0.430 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 137 | 0.420 |
Why?
|
| Insurance, Health | 1 | 2014 | 138 | 0.420 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2013 | 23 | 0.410 |
Why?
|
| Premature Birth | 1 | 2017 | 384 | 0.410 |
Why?
|
| Patient Safety | 1 | 2017 | 398 | 0.410 |
Why?
|
| Disease Management | 1 | 2016 | 521 | 0.410 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 85 | 0.410 |
Why?
|
| Facial Bones | 1 | 2012 | 28 | 0.390 |
Why?
|
| Blood Pressure | 8 | 2014 | 1348 | 0.380 |
Why?
|
| Medicaid | 1 | 2014 | 243 | 0.380 |
Why?
|
| Cell Cycle | 4 | 2019 | 615 | 0.380 |
Why?
|
| Cleft Lip | 1 | 2013 | 125 | 0.380 |
Why?
|
| Cleft Palate | 1 | 2013 | 140 | 0.380 |
Why?
|
| Endothelial Cells | 3 | 2025 | 526 | 0.370 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 374 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 410 | 0.360 |
Why?
|
| Pancreas | 2 | 2025 | 217 | 0.360 |
Why?
|
| Heart Ventricles | 3 | 2021 | 767 | 0.340 |
Why?
|
| Hyperuricemia | 1 | 2010 | 37 | 0.340 |
Why?
|
| Mammals | 2 | 2023 | 260 | 0.330 |
Why?
|
| Hepatocytes | 2 | 2025 | 229 | 0.330 |
Why?
|
| Hemodynamics | 1 | 2014 | 850 | 0.330 |
Why?
|
| T-Box Domain Proteins | 3 | 2020 | 121 | 0.320 |
Why?
|
| Stem Cells | 6 | 2019 | 702 | 0.320 |
Why?
|
| Gene Expression | 1 | 2013 | 1570 | 0.310 |
Why?
|
| Female | 30 | 2023 | 66555 | 0.310 |
Why?
|
| Pregnancy, Animal | 3 | 2014 | 76 | 0.310 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2022 | 215 | 0.310 |
Why?
|
| Stroke | 1 | 2016 | 986 | 0.310 |
Why?
|
| Repressor Proteins | 3 | 2022 | 820 | 0.300 |
Why?
|
| Animals, Newborn | 4 | 2021 | 1010 | 0.300 |
Why?
|
| Cell Lineage | 2 | 2021 | 348 | 0.300 |
Why?
|
| Base Sequence | 6 | 2018 | 3099 | 0.300 |
Why?
|
| Atrial Fibrillation | 3 | 2025 | 661 | 0.280 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 675 | 0.280 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2538 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 4430 | 0.270 |
Why?
|
| Gene Deletion | 5 | 2019 | 795 | 0.270 |
Why?
|
| Alleles | 3 | 2021 | 1618 | 0.270 |
Why?
|
| Gene Editing | 3 | 2025 | 194 | 0.270 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2019 | 382 | 0.260 |
Why?
|
| DNA-Binding Proteins | 4 | 2024 | 2059 | 0.250 |
Why?
|
| Reactive Oxygen Species | 4 | 2025 | 492 | 0.250 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2025 | 10 | 0.240 |
Why?
|
| Erythroid Cells | 2 | 2024 | 26 | 0.240 |
Why?
|
| Genes, Essential | 1 | 2025 | 41 | 0.240 |
Why?
|
| Gene Expression Profiling | 5 | 2025 | 1697 | 0.240 |
Why?
|
| Morphogenesis | 2 | 2018 | 212 | 0.230 |
Why?
|
| Histidine | 1 | 2024 | 72 | 0.230 |
Why?
|
| Endothelium, Vascular | 2 | 2025 | 523 | 0.230 |
Why?
|
| Gene Targeting | 1 | 2025 | 179 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 2 | 2022 | 459 | 0.220 |
Why?
|
| Ischemia | 3 | 2012 | 357 | 0.220 |
Why?
|
| Methylation | 1 | 2024 | 224 | 0.220 |
Why?
|
| Apoptosis | 3 | 2022 | 1791 | 0.220 |
Why?
|
| Pregnancy in Diabetics | 1 | 2023 | 20 | 0.220 |
Why?
|
| Methyltransferases | 1 | 2024 | 71 | 0.220 |
Why?
|
| Vascular Resistance | 2 | 2014 | 186 | 0.220 |
Why?
|
| Dioxygenases | 1 | 2024 | 46 | 0.220 |
Why?
|
| Receptors, Steroid | 2 | 2020 | 275 | 0.210 |
Why?
|
| Genetic Vectors | 2 | 2019 | 940 | 0.210 |
Why?
|
| Oxidative Stress | 4 | 2018 | 807 | 0.210 |
Why?
|
| Placenta | 6 | 2014 | 507 | 0.210 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2012 | 60 | 0.210 |
Why?
|
| CRISPR-Cas Systems | 2 | 2017 | 262 | 0.210 |
Why?
|
| Hypertension | 3 | 2017 | 1314 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2018 | 3061 | 0.210 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2013 | 23 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 1341 | 0.200 |
Why?
|
| Image Cytometry | 1 | 2022 | 13 | 0.200 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2022 | 10 | 0.200 |
Why?
|
| HeLa Cells | 1 | 2024 | 809 | 0.200 |
Why?
|
| Cell Line | 3 | 2018 | 2771 | 0.200 |
Why?
|
| RNA, Messenger | 4 | 2017 | 2825 | 0.200 |
Why?
|
| Transgenes | 2 | 2025 | 337 | 0.200 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 9 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2025 | 554 | 0.200 |
Why?
|
| Homocystinuria | 1 | 2022 | 21 | 0.190 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 40 | 0.190 |
Why?
|
| Risk Assessment | 3 | 2017 | 3435 | 0.190 |
Why?
|
| Oxidoreductases | 1 | 2022 | 93 | 0.190 |
Why?
|
| Histone Chaperones | 1 | 2021 | 11 | 0.190 |
Why?
|
| Heart Atria | 2 | 2025 | 316 | 0.190 |
Why?
|
| Cardiology | 2 | 2017 | 502 | 0.190 |
Why?
|
| Genetic Therapy | 2 | 2017 | 683 | 0.190 |
Why?
|
| Dependovirus | 2 | 2019 | 130 | 0.180 |
Why?
|
| Ribosomes | 1 | 2022 | 138 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 619 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 229 | 0.180 |
Why?
|
| Immunomagnetic Separation | 1 | 2021 | 12 | 0.180 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2021 | 97 | 0.180 |
Why?
|
| Smad1 Protein | 2 | 2013 | 22 | 0.180 |
Why?
|
| Cyclohexanones | 1 | 2020 | 19 | 0.180 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 98 | 0.180 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 53 | 0.180 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 4356 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 543 | 0.180 |
Why?
|
| Ventricular Function | 1 | 2021 | 91 | 0.180 |
Why?
|
| Mesoderm | 3 | 2025 | 113 | 0.180 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 157 | 0.180 |
Why?
|
| Tetralogy of Fallot | 1 | 2022 | 162 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 214 | 0.170 |
Why?
|
| Histones | 2 | 2021 | 535 | 0.170 |
Why?
|
| Uterus | 3 | 2013 | 570 | 0.170 |
Why?
|
| Monocytes | 1 | 2022 | 354 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 354 | 0.170 |
Why?
|
| Anemia | 1 | 2024 | 340 | 0.170 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 366 | 0.170 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 181 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 154 | 0.170 |
Why?
|
| Tamoxifen | 1 | 2021 | 363 | 0.160 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2019 | 3 | 0.160 |
Why?
|
| Endoderm | 1 | 2019 | 25 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 23 | 0.160 |
Why?
|
| Triage | 2 | 2017 | 140 | 0.160 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2019 | 35 | 0.160 |
Why?
|
| Early Diagnosis | 2 | 2018 | 181 | 0.160 |
Why?
|
| Saccule and Utricle | 1 | 2019 | 12 | 0.160 |
Why?
|
| Infant Mortality | 2 | 2010 | 173 | 0.160 |
Why?
|
| Swine | 1 | 2023 | 1173 | 0.160 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2022 | 252 | 0.160 |
Why?
|
| Pyridines | 1 | 2020 | 230 | 0.160 |
Why?
|
| Diploidy | 1 | 2019 | 35 | 0.160 |
Why?
|
| Infant, Newborn | 3 | 2023 | 8182 | 0.160 |
Why?
|
| Hair Cells, Auditory | 1 | 2019 | 62 | 0.160 |
Why?
|
| Gene Regulatory Networks | 4 | 2025 | 355 | 0.160 |
Why?
|
| Electron Transport Complex IV | 1 | 2018 | 39 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 1 | 2019 | 106 | 0.150 |
Why?
|
| Mutation | 7 | 2022 | 5812 | 0.150 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2018 | 20 | 0.150 |
Why?
|
| Cell Division | 2 | 2018 | 782 | 0.150 |
Why?
|
| Trans-Activators | 3 | 2019 | 808 | 0.150 |
Why?
|
| Action Potentials | 2 | 2019 | 502 | 0.150 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 105 | 0.150 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2018 | 23 | 0.150 |
Why?
|
| Cardiomegaly | 1 | 2019 | 131 | 0.150 |
Why?
|
| Ploidies | 1 | 2018 | 37 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 196 | 0.150 |
Why?
|
| Gestational Age | 2 | 2014 | 1161 | 0.150 |
Why?
|
| Heart Rate | 1 | 2020 | 594 | 0.150 |
Why?
|
| Binding Sites | 1 | 2021 | 1297 | 0.150 |
Why?
|
| Risk Factors | 3 | 2023 | 10272 | 0.150 |
Why?
|
| Fetal Heart | 1 | 2018 | 117 | 0.140 |
Why?
|
| Olfactory Bulb | 1 | 2018 | 96 | 0.140 |
Why?
|
| Quality Control | 1 | 2017 | 119 | 0.140 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 46 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3881 | 0.140 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 296 | 0.140 |
Why?
|
| Regenerative Medicine | 1 | 2017 | 30 | 0.140 |
Why?
|
| Consensus | 2 | 2017 | 634 | 0.140 |
Why?
|
| Insulin Resistance | 1 | 2022 | 645 | 0.140 |
Why?
|
| Neuroglia | 1 | 2019 | 201 | 0.140 |
Why?
|
| Developed Countries | 1 | 2017 | 36 | 0.140 |
Why?
|
| Health Priorities | 1 | 2017 | 36 | 0.140 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 165 | 0.140 |
Why?
|
| Neurogenesis | 1 | 2018 | 190 | 0.140 |
Why?
|
| Sumoylation | 1 | 2017 | 37 | 0.130 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 632 | 0.130 |
Why?
|
| Genetic Markers | 1 | 2018 | 606 | 0.130 |
Why?
|
| Cardiotoxicity | 1 | 2016 | 34 | 0.130 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 30 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 104 | 0.130 |
Why?
|
| Electron Transport | 1 | 2016 | 55 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2017 | 77 | 0.130 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 49 | 0.130 |
Why?
|
| Women's Health | 1 | 2017 | 133 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 197 | 0.130 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 23 | 0.130 |
Why?
|
| Disease Progression | 1 | 2022 | 2055 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 105 | 0.130 |
Why?
|
| Embryo Loss | 1 | 2015 | 26 | 0.130 |
Why?
|
| Health Services Research | 1 | 2017 | 188 | 0.130 |
Why?
|
| Retina | 1 | 2019 | 453 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2017 | 176 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2018 | 348 | 0.120 |
Why?
|
| Emergency Medicine | 1 | 2017 | 155 | 0.120 |
Why?
|
| Outpatients | 1 | 2017 | 255 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 236 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 129 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2018 | 471 | 0.120 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 113 | 0.120 |
Why?
|
| Endothelin-1 | 2 | 2012 | 40 | 0.120 |
Why?
|
| RNA Interference | 2 | 2014 | 504 | 0.120 |
Why?
|
| Hydroxyprogesterones | 1 | 2014 | 6 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 355 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2016 | 213 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2014 | 1229 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 1943 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 160 | 0.120 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2014 | 4 | 0.120 |
Why?
|
| Albinism | 1 | 2014 | 8 | 0.120 |
Why?
|
| Monophenol Monooxygenase | 1 | 2014 | 20 | 0.120 |
Why?
|
| Liver | 2 | 2025 | 1764 | 0.120 |
Why?
|
| Uterine Artery | 1 | 2014 | 29 | 0.120 |
Why?
|
| Pigmentation | 1 | 2014 | 35 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2015 | 241 | 0.110 |
Why?
|
| Cell Physiological Phenomena | 1 | 2014 | 16 | 0.110 |
Why?
|
| Young Adult | 3 | 2014 | 8987 | 0.110 |
Why?
|
| Endonucleases | 1 | 2014 | 54 | 0.110 |
Why?
|
| Genome | 1 | 2017 | 476 | 0.110 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 597 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2012 | 84 | 0.110 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 195 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2017 | 417 | 0.110 |
Why?
|
| Thorax | 1 | 2014 | 72 | 0.110 |
Why?
|
| SOX9 Transcription Factor | 1 | 2014 | 80 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 538 | 0.110 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2013 | 17 | 0.110 |
Why?
|
| Rats | 6 | 2021 | 3689 | 0.110 |
Why?
|
| Mullerian Ducts | 1 | 2013 | 33 | 0.110 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 177 | 0.110 |
Why?
|
| Hydrocephalus | 1 | 2015 | 244 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 163 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2014 | 121 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2015 | 348 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 1272 | 0.100 |
Why?
|
| Models, Biological | 1 | 2018 | 1461 | 0.100 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 235 | 0.100 |
Why?
|
| Reference Values | 1 | 2014 | 712 | 0.100 |
Why?
|
| Mosaicism | 1 | 2014 | 241 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 1113 | 0.100 |
Why?
|
| Adult | 5 | 2014 | 29472 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2015 | 466 | 0.100 |
Why?
|
| Headache | 1 | 2013 | 109 | 0.100 |
Why?
|
| Neural Tube Defects | 1 | 2015 | 351 | 0.100 |
Why?
|
| beta Catenin | 1 | 2013 | 206 | 0.100 |
Why?
|
| Male | 11 | 2025 | 61285 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 300 | 0.100 |
Why?
|
| Interleukin-17 | 1 | 2012 | 119 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 670 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 530 | 0.090 |
Why?
|
| Plasma Exchange | 1 | 2012 | 84 | 0.090 |
Why?
|
| Autoantibodies | 2 | 2011 | 436 | 0.090 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 250 | 0.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 79 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 489 | 0.090 |
Why?
|
| United States | 2 | 2017 | 10886 | 0.090 |
Why?
|
| Apgar Score | 1 | 2010 | 47 | 0.090 |
Why?
|
| Cesarean Section | 1 | 2014 | 387 | 0.090 |
Why?
|
| Parity | 1 | 2010 | 78 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2010 | 112 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2013 | 16299 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2012 | 626 | 0.090 |
Why?
|
| Epithelium | 2 | 2013 | 362 | 0.080 |
Why?
|
| Stillbirth | 1 | 2010 | 80 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 361 | 0.080 |
Why?
|
| Calcium | 1 | 2014 | 1098 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2018 | 12342 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 475 | 0.080 |
Why?
|
| Serum Response Factor | 1 | 2008 | 29 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 887 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2013 | 910 | 0.080 |
Why?
|
| Muscle Development | 2 | 2008 | 71 | 0.080 |
Why?
|
| Birth Weight | 1 | 2010 | 348 | 0.080 |
Why?
|
| Biomarkers | 3 | 2018 | 3063 | 0.080 |
Why?
|
| Neurons | 1 | 2018 | 1966 | 0.080 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2010 | 171 | 0.070 |
Why?
|
| Ovary | 2 | 2007 | 381 | 0.070 |
Why?
|
| Spleen | 2 | 2024 | 282 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2008 | 238 | 0.070 |
Why?
|
| Smad5 Protein | 1 | 2007 | 22 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1664 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 127 | 0.070 |
Why?
|
| Decidua | 1 | 2007 | 140 | 0.070 |
Why?
|
| Branchial Region | 1 | 2005 | 8 | 0.060 |
Why?
|
| Testis | 1 | 2007 | 411 | 0.060 |
Why?
|
| Comorbidity | 1 | 2010 | 1531 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3448 | 0.060 |
Why?
|
| Pyroptosis | 1 | 2025 | 26 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 667 | 0.060 |
Why?
|
| Hydrolases | 1 | 2025 | 58 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2090 | 0.060 |
Why?
|
| Atrial Appendage | 1 | 2025 | 46 | 0.060 |
Why?
|
| Arteries | 1 | 2005 | 219 | 0.060 |
Why?
|
| Extremities | 1 | 2004 | 83 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2025 | 427 | 0.060 |
Why?
|
| Adolescent | 2 | 2013 | 19329 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2013 | 4783 | 0.050 |
Why?
|
| Child | 1 | 2023 | 24454 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2025 | 150 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2014 | 6137 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2004 | 210 | 0.050 |
Why?
|
| Incidence | 1 | 2010 | 3144 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2018 | 803 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2018 | 470 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 16 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2788 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 55 | 0.050 |
Why?
|
| Spin Labels | 2 | 2012 | 39 | 0.050 |
Why?
|
| Cyclic N-Oxides | 2 | 2012 | 30 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2012 | 63 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 73 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2014 | 867 | 0.050 |
Why?
|
| Brain | 2 | 2025 | 3010 | 0.050 |
Why?
|
| DNA Repair | 1 | 2025 | 587 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 48 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3587 | 0.050 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 44 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2022 | 165 | 0.050 |
Why?
|
| Iron | 1 | 2024 | 268 | 0.050 |
Why?
|
| Cell Transdifferentiation | 1 | 2021 | 66 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 39 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 56 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2015 | 230 | 0.040 |
Why?
|
| Rituximab | 2 | 2012 | 156 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 869 | 0.040 |
Why?
|
| Models, Animal | 2 | 2012 | 465 | 0.040 |
Why?
|
| Infertility, Female | 2 | 2013 | 145 | 0.040 |
Why?
|
| Cyclin D3 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 220 | 0.040 |
Why?
|
| Inflammation | 2 | 2020 | 1428 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 64 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 824 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2019 | 112 | 0.040 |
Why?
|
| Infant | 1 | 2014 | 12483 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2011 | 1017 | 0.040 |
Why?
|
| Cochlea | 1 | 2019 | 85 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 665 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 239 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 954 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 153 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 290 | 0.040 |
Why?
|
| Interneurons | 1 | 2018 | 142 | 0.040 |
Why?
|
| RNA | 1 | 2020 | 568 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 356 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 618 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2017 | 133 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2017 | 89 | 0.030 |
Why?
|
| Telomere Shortening | 1 | 2016 | 33 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 147 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 16 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 367 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 551 | 0.030 |
Why?
|
| Progesterone Congeners | 1 | 2014 | 6 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 352 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 444 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 284 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2817 | 0.030 |
Why?
|
| Melanins | 1 | 2014 | 18 | 0.030 |
Why?
|
| Zygote | 1 | 2014 | 24 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2014 | 21 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 103 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 410 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 441 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 177 | 0.030 |
Why?
|
| Vasodilation | 1 | 2014 | 190 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 84 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 515 | 0.030 |
Why?
|
| Myometrium | 1 | 2013 | 47 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2014 | 347 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 165 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 383 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2014 | 242 | 0.030 |
Why?
|
| Isoprostanes | 1 | 2012 | 3 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 384 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 710 | 0.030 |
Why?
|
| Receptor, Endothelin A | 1 | 2012 | 12 | 0.030 |
Why?
|
| Endothelin A Receptor Antagonists | 1 | 2012 | 9 | 0.030 |
Why?
|
| Pyrrolidines | 1 | 2012 | 36 | 0.020 |
Why?
|
| Losartan | 1 | 2012 | 35 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 701 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 486 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 98 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 1069 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2012 | 55 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 299 | 0.020 |
Why?
|
| Sarcoma | 1 | 2013 | 194 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 42 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 237 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2012 | 174 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 282 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 116 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 577 | 0.020 |
Why?
|
| GATA6 Transcription Factor | 1 | 2008 | 11 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2008 | 88 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 1495 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 1761 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1291 | 0.020 |
Why?
|
| Smad8 Protein | 1 | 2007 | 6 | 0.020 |
Why?
|
| Sertoli Cell Tumor | 1 | 2007 | 8 | 0.020 |
Why?
|
| Granulosa Cell Tumor | 1 | 2007 | 40 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3287 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 224 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 170 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 66 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 133 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 159 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2007 | 195 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 208 | 0.020 |
Why?
|
| Pharynx | 1 | 2005 | 64 | 0.020 |
Why?
|
| Fertility | 1 | 2007 | 257 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 314 | 0.020 |
Why?
|
| Cytokines | 1 | 2011 | 1291 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2007 | 234 | 0.020 |
Why?
|
| COUP Transcription Factors | 1 | 2004 | 43 | 0.010 |
Why?
|
| Blastocyst | 1 | 2004 | 75 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6309 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 759 | 0.010 |
Why?
|
| COUP Transcription Factor II | 1 | 2004 | 117 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 441 | 0.010 |
Why?
|
| Middle Aged | 2 | 2015 | 26717 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 534 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 835 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 528 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1690 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 1899 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 19691 | 0.010 |
Why?
|